The global cell line development market is on a trajectory of impressive growth, fueled by the surging demand for biologics and next-generation therapeutics. Valued at USD 6.17 billion in 2024, the market is projected to expand at a robust CAGR of 9.6% during the forecast period from 2025 to 2034, ultimately reaching a value of USD 15.43 billion by 2034....